General
Preferred name
BUCLIZINE
Synonyms
Longifene ()
Buclina ()
Buclizine HCl ()
UCB-4445 ()
BUCLIZINE HYDROCHLORIDE ()
Buclizine (dihydrochloride) ()
Buclizine dihydrochloride ()
Buclizina ()
Buclodin ()
Bucladin ()
Vibazine ()
Bucladin-S ()
Equivert ()
Softran ()
NSC-25141 ()
Aphilan ()
UCB 4445 ()
Buclizine (hydrochloride) ()
P&D ID
PD010084
CAS
82-95-1
129-74-8
Tags
available
drug
Approved by
FDA
Drug indication
Nausea
allergic disease
Drug Status
approved
withdrawn
Max Phase
4.0
First approval
1982
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Buclizine is a piperazine derivative antihistamine and anticholinergic drug, with antiemetic properties. (GtoPdb)
PRICE 29
DESCRIPTION Buclizine dihydrochloride (Buclina) is the hydrochloride salt form of buclizine, a piperazine histamine H1 receptor antagonist with primarily antiemetic and antivertigo activities. Buclizine dihydrochloride binds to and blocks the histamine H1 receptor, thereby preventing the symptoms that are caused by histamine activity. Buclizine dihydrochloride exerts its anti-emetic effect by binding to and blocking the muscarinic and histamine receptors in the vomiting center of the central nervous system (CNS). This may prevent activation of the chemoreceptor trigger zone (CTZ) and may reduce nausea and vomiting. (TargetMol Bioactive Compound Library)
Compound Sets
18
Cayman Chemical Bioactives
ChEMBL Approved Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
Other bioactive compounds
ReFrame library
TargetMol Bioactive Compound Library
Withdrawn 2.0
External IDs
62
Properties
(calculated by RDKit )
Molecular Weight
432.23
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
0
Rotatable Bonds
5
Ring Count
4
Aromatic Ring Count
3
cLogP
6.54
TPSA
6.48
Fraction CSP3
0.36
Chiral centers
1.0
Largest ring
6.0
QED
0.45
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
GPCR/G protein
Immunology/Inflammation
Neuroscience
Neuronal Signaling
ATC
R06AE01
Therapeutic Class
Antihistamines
Target
Histamine Receptor
Cholinergic
HT
Source data